ShockWave Medical, Inc.
SWAV · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | $219 | $203 | $186 | $180 |
| % Growth | 7.8% | 9.1% | 3.2% | – |
| Cost of Goods Sold | $28 | $25 | $25 | $24 |
| Gross Profit | $191 | $178 | $162 | $156 |
| % Margin | 87.1% | 87.5% | 86.8% | 86.4% |
| R&D Expenses | $44 | $42 | $40 | $37 |
| G&A Expenses | $29 | $25 | $21 | $30 |
| SG&A Expenses | $104 | $92 | $78 | $86 |
| Sales & Mktg Exp. | $74 | $67 | $57 | $57 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $148 | $133 | $118 | $123 |
| Operating Income | $42 | $45 | $44 | $32 |
| % Margin | 19.4% | 22% | 23.5% | 18% |
| Other Income/Exp. Net | $8 | $11 | $1 | $1 |
| Pre-Tax Income | $50 | $55 | $45 | $33 |
| Tax Expense | -$5 | $11 | $10 | $4 |
| Net Income | $55 | $44 | $35 | $29 |
| % Margin | 25.3% | 21.8% | 18.8% | 16% |
| EPS | 1.48 | 1.2 | 0.95 | 0.79 |
| % Growth | 23.3% | 26.3% | 20.3% | – |
| EPS Diluted | 1.44 | 1.16 | 0.92 | 0.76 |
| Weighted Avg Shares Out | 37 | 37 | 37 | 37 |
| Weighted Avg Shares Out Dil | 38 | 38 | 38 | 38 |
| Supplemental Information | – | – | – | – |
| Interest Income | $12 | $0 | $3 | $1 |
| Interest Expense | $3 | $3 | $3 | $1 |
| Depreciation & Amortization | $3 | $3 | $3 | $3 |
| EBITDA | $56 | $61 | $51 | $36 |
| % Margin | 25.6% | 30.3% | 27.2% | 20.2% |